Overview

Can Caudal Dexmedetomidine Provide Effective Analgesia?

Status:
Not yet recruiting

Trial end date:
2024-09-01

Target enrollment:
0

Participant gender:
All

Summary

The goal of this clinical trial is to evaluate if caudal dexmedetomidine can provide effective analgesia during inguinoscrotal surgeries in pediatrics, if used caudally alone (and not as an adjunct to caudal bupivacaine). The main question it aims to answer is: - Can caudal dexmedetomidine provide effective analgesia? Participants will be pediatrics aged from 1 to 6 years ASA-I and ASA-II undergoing inguinoscrotal surgeries. - A total of 50 pediatric patients who will undergo inguinoscrotal surgery will be allocated randomly into 2 equal groups: - Group B (n =25): In this group, and after induction of general anesthesia, pediatric patients will receive a caudal injection of bupivacaine 0.125 % in a dose of 1ml/kg. - Group D (n =25): In this group, and after injection of general anesthesia, pediatric patients will receive a caudal injection of dexmedetomidine in a dose of 1.5 mcg/kg.

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Benha University

Treatments:

Bupivacaine
Dexmedetomidine

Criteria

Inclusion Criteria:

- ASA-I and ASA-II pediatric patients (age :1-6 years old)

- Inguinoscrotal surgeries

Exclusion Criteria:

- Patient's parent's refusal

- Unable to give consent

- Known allergy to the study medications

- Coagulopathies or on anticoagulant medications

- ASA-III or ASA-IV